(Q45628216)

14 December 2017

title

Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing (English)

1 reference

Simian immunodeficiency virus

14 December 2017

main subject

0 references

author

Huanliang Liu

series ordinal

5

1 reference

14 December 2017

9

Lawrence Corey

1 reference

14 December 2017

8

James I Mullins

1 reference

14 December 2017

7

Gerald H Learn

1 reference

14 December 2017

1

Tuofu Zhu

1 reference

14 December 2017

6

Yon Hwangbo

1 reference

14 December 2017

Shiu-Lok Hu

2

1 reference

14 December 2017

Feng Feng

series ordinal

3

1 reference

14 December 2017

Patricia Polacino

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 December 2017

1 reference

14 December 2017

volume

323

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

208-219

1 reference

A new look at the statistical model identification

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Clearance of HIV infection in a perinatally infected infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Long-term HIV-1 infection without immunologic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

The U3 promoter region of the acutely lethal simian immunodeficiency virus clone smmPBj1.9 confers related biological activity on the apathogenic clone agm3mc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Genetic evaluation of suspected cases of transient HIV-1 infection of infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Silent HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

HIV clearance in an infant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

MODELTEST: testing the model of DNA substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.004

7 January 2021

10.1016/J.VIROL.2004.03.004

Identifiers

DOI

1 reference

14 December 2017

1 reference